334.80
price down icon1.03%   -3.485
after-market 시간 외 거래: 345.00 10.20 +3.05%
loading

Madrigal Pharmaceuticals Inc 주식(MDGL)의 최신 뉴스

pulisher
Jan 29, 2025

Madrigal Pharmaceuticals CEO sells shares worth $531,020 - MSN

Jan 29, 2025
pulisher
Jan 29, 2025

(01/29/25) Top Picks 2025: Madrigal Pharmaceuticals (MDGL) - Moneyshow.com

Jan 29, 2025
pulisher
Jan 27, 2025

Madrigal Pharmaceuticals chief commercial officer sells $116,328 in stock - MSN

Jan 27, 2025
pulisher
Jan 27, 2025

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Insider Carole Huntsman Sells 347 Shares - MarketBeat

Jan 27, 2025
pulisher
Jan 27, 2025

Insider Selling: Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) CEO Sells 1,584 Shares of Stock - MarketBeat

Jan 27, 2025
pulisher
Jan 27, 2025

Insider Selling: Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) CMO Sells 648 Shares of Stock - MarketBeat

Jan 27, 2025
pulisher
Jan 27, 2025

Insider Selling: Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) VP Sells 103 Shares of Stock - MarketBeat

Jan 27, 2025
pulisher
Jan 27, 2025

Madrigal Pharmaceuticals executive sells shares worth $34,529 - MSN

Jan 27, 2025
pulisher
Jan 27, 2025

Madrigal Pharmaceuticals chief commercial officer sells $116,328 in stock By Investing.com - Investing.com South Africa

Jan 27, 2025
pulisher
Jan 27, 2025

Madrigal Pharmaceuticals CEO sells shares worth $531,020 By Investing.com - Investing.com Australia

Jan 27, 2025
pulisher
Jan 27, 2025

Madrigal Pharmaceuticals executive sells shares worth $34,529 By Investing.com - Investing.com Canada

Jan 27, 2025
pulisher
Jan 27, 2025

(MDGL) Trading Advice - Stock Traders Daily

Jan 27, 2025
pulisher
Jan 24, 2025

Madrigal Pharmaceuticals (MDGL) Stock Price, News & Analysis - MarketBeat

Jan 24, 2025
pulisher
Jan 23, 2025

Exploring Three High Growth Tech Stocks in the United States - Yahoo Finance

Jan 23, 2025
pulisher
Jan 23, 2025

Brokers Issue Forecasts for MDGL FY2025 Earnings - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Cantor Fitzgerald Estimates MDGL FY2025 Earnings - Defense World

Jan 23, 2025
pulisher
Jan 22, 2025

MDGL (Madrigal Pharmaceuticals) Long-Term Debt & Capital Le - GuruFocus.com

Jan 22, 2025
pulisher
Jan 22, 2025

Cantor Fitzgerald Predicts MDGL FY2025 Earnings - MarketBeat

Jan 22, 2025
pulisher
Jan 21, 2025

MDGL (Madrigal Pharmaceuticals) Dividends per Share : $0.00 (TTM As of Sep. 2024) - GuruFocus.com

Jan 21, 2025
pulisher
Jan 21, 2025

Madrigal Pharmaceuticals’ Treatment Could Be a Blockbuster in the Making - TipRanks

Jan 21, 2025
pulisher
Jan 21, 2025

MDGL Stock Down 10% on Disappointing Preliminary Q4 Rezdiffra Sales - MSN

Jan 21, 2025
pulisher
Jan 20, 2025

MDGL (Madrigal Pharmaceuticals) Change In Working Capital : $7.82 Mil (TTM As of Sep. 2024) - GuruFocus.com

Jan 20, 2025
pulisher
Jan 19, 2025

Madrigal Pharmaceuticals exec sells $461,789 in stock - MSN

Jan 19, 2025
pulisher
Jan 19, 2025

Madrigal Pharmaceuticals gains amid takeover speculation - MSN

Jan 19, 2025
pulisher
Jan 19, 2025

MDGL (Madrigal Pharmaceuticals) Quick Ratio : 5.93 (As of Sep. 2024) - GuruFocus.com

Jan 19, 2025
pulisher
Jan 19, 2025

Madrigal Pharmaceuticals Rezdiffra Vies For Blockbuster Status In MASH - Seeking Alpha

Jan 19, 2025
pulisher
Jan 19, 2025

Have Insiders Sold Madrigal Pharmaceuticals Shares Recently? - Simply Wall St

Jan 19, 2025
pulisher
Jan 19, 2025

MDGL (Madrigal Pharmaceuticals) Net Income From Continuing Operations : $-518.67 Mil (TTM As of Sep. 2024) - GuruFocus.com

Jan 19, 2025
pulisher
Jan 19, 2025

MDGL (Madrigal Pharmaceuticals) EV-to-EBITDA : -10.99 (As of Jan. 19, 2025) - GuruFocus.com

Jan 19, 2025
pulisher
Jan 19, 2025

MDGL (Madrigal Pharmaceuticals) Capex-to-Operating-Cash-Flo - GuruFocus.com

Jan 19, 2025
pulisher
Jan 19, 2025

MDGL (Madrigal Pharmaceuticals) Earnings Yield % : N/A% (As of Jan. 19, 2025) - GuruFocus.com

Jan 19, 2025
pulisher
Jan 19, 2025

MDGL (Madrigal Pharmaceuticals) 3-Year Book Growth Rate : 9.60% (As of Sep. 2024) - GuruFocus.com

Jan 19, 2025
pulisher
Jan 19, 2025

MDGL (Madrigal Pharmaceuticals) Cash Flow for Lease Financing : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com

Jan 19, 2025
pulisher
Jan 19, 2025

MDGL (Madrigal Pharmaceuticals) Debt-to-Asset : 0.11 (As of Sep. 2024) - GuruFocus.com

Jan 19, 2025
pulisher
Jan 18, 2025

Madrigal Pharmaceuticals executive sells shares worth $120,847 - MSN

Jan 18, 2025
pulisher
Jan 18, 2025

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) VP Robert E. Waltermire Sells 442 Shares - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) CMO Sells $461,789.49 in Stock - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

Madrigal Pharmaceuticals exec sells $461,789 in stock By Investing.com - Investing.com South Africa

Jan 18, 2025
pulisher
Jan 18, 2025

Madrigal Pharmaceuticals general counsel sells $75,734 in stock By Investing.com - Investing.com Australia

Jan 18, 2025
pulisher
Jan 18, 2025

Madrigal Pharmaceuticals general counsel sells $75,734 in stock - Investing.com India

Jan 18, 2025
pulisher
Jan 18, 2025

Madrigal Pharmaceuticals (NASDAQ:MDGL) Trading Up 7.4%Should You Buy? - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

Shannon T. Kelley Sells 277 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

Madrigal Pharmaceuticals executive sells shares worth $120,847 By Investing.com - Investing.com Canada

Jan 18, 2025
pulisher
Jan 17, 2025

Madrigral Pharmaceuticals gains amid takeover speculation - MSN

Jan 17, 2025
pulisher
Jan 17, 2025

Why Madrigal Pharmaceuticals Stock Was Plummeting This Week - MSN

Jan 17, 2025
pulisher
Jan 17, 2025

Madrigal Reports Robust 2024 Performance and Plans for Growth - MSN

Jan 17, 2025
pulisher
Jan 17, 2025

Why Madrigal Pharmaceuticals (MDGL) Stock is Moving Today - GuruFocus.com

Jan 17, 2025
$39.42
price down icon 3.95%
$351.17
price down icon 0.32%
$21.50
price down icon 3.85%
$5.30
price down icon 2.03%
biotechnology ONC
$224.99
price down icon 0.84%
$123.77
price up icon 2.39%
자본화:     |  볼륨(24시간):